SIGMA TAU FINANZIARIA SPA 13D and 13G filings for RegeneRx Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-07-06 4:35 pm Purchase |
2023-07-03 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX |
SIGMA TAU FINANZIARIA SPA | 6,040 36.100% |
513 (+9.27%) |
Filing |
| 2021-07-02 4:15 pm Purchase |
2021-06-30 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX |
SIGMA TAU FINANZIARIA SPA | 5,527 34.100% |
375 (+7.28%) |
Filing |
| 2020-10-16 4:16 pm Purchase |
2020-10-15 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX |
SIGMA TAU FINANZIARIA SPA | 5,152 34.400% |
195 (+3.93%) |
Filing |